ARQT logo

Arcutis Biotherapeutics (ARQT) Accounts receivable

Annual accounts receivable:

$73.07M+$47.26M(+183.12%)
December 31, 2024

Summary

  • As of today (May 30, 2025), ARQT annual accounts receivable is $73.07 million, with the most recent change of +$47.26 million (+183.12%) on December 31, 2024.
  • During the last 3 years, ARQT annual accounts receivable has risen by +$73.07 million (+100.00%).
  • ARQT annual accounts receivable is now at all-time high.

Performance

ARQT Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTbalance sheet metrics

Quarterly accounts receivable:

$85.42M+$12.35M(+16.90%)
March 31, 2025

Summary

  • As of today (May 30, 2025), ARQT quarterly accounts receivable is $85.42 million, with the most recent change of +$12.35 million (+16.90%) on March 31, 2025.
  • Over the past year, ARQT quarterly accounts receivable has increased by +$48.26 million (+129.89%).
  • ARQT quarterly accounts receivable is now at all-time high.

Performance

ARQT Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTbalance sheet metrics

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

ARQT Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+183.1%+129.9%
3 y3 years+100.0%-
5 y5 years--

ARQT Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high>+9999.0%at high+3413.6%
5 y5-yearat high>+9999.0%at high>+9999.0%
alltimeall timeat high>+9999.0%at high>+9999.0%

ARQT Accounts receivable History

DateAnnualQuarterly
Mar 2025
-
$85.42M(+16.9%)
Dec 2024
$73.07M(+183.1%)
$73.07M(+21.5%)
Sep 2024
-
$60.12M(+38.5%)
Jun 2024
-
$43.41M(+16.8%)
Mar 2024
-
$37.15M(+44.0%)
Dec 2023
$25.81M
$25.81M(+32.9%)
DateAnnualQuarterly
Sep 2023
-
$19.42M(+12.8%)
Jun 2023
-
$17.21M(+34.8%)
Mar 2023
-
$12.77M(+51.0%)
Dec 2022
$8.46M(>+9900.0%)
$8.46M(+247.9%)
Sep 2022
-
$2.43M(>+9900.0%)
Dec 2021
$0.00
$0.00

FAQ

  • What is Arcutis Biotherapeutics annual accounts receivable?
  • What is the all time high annual accounts receivable for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics annual accounts receivable year-on-year change?
  • What is Arcutis Biotherapeutics quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics quarterly accounts receivable year-on-year change?

What is Arcutis Biotherapeutics annual accounts receivable?

The current annual accounts receivable of ARQT is $73.07M

What is the all time high annual accounts receivable for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high annual accounts receivable is $73.07M

What is Arcutis Biotherapeutics annual accounts receivable year-on-year change?

Over the past year, ARQT annual accounts receivable has changed by +$47.26M (+183.12%)

What is Arcutis Biotherapeutics quarterly accounts receivable?

The current quarterly accounts receivable of ARQT is $85.42M

What is the all time high quarterly accounts receivable for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high quarterly accounts receivable is $85.42M

What is Arcutis Biotherapeutics quarterly accounts receivable year-on-year change?

Over the past year, ARQT quarterly accounts receivable has changed by +$48.26M (+129.89%)
On this page